Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

Radiology societies fight Medicare Administrative Contractor’s proposed coverage restriction
National Government Services is seeking to limit the use of thermal destruction of the intraosseous basivertebral nerve, aka the Intracept procedure, drawing ire from ACR and SIR.
Company seeks to become a ‘leader in interventional radiology’ with recent acquisition
Quantum Surgical, which specializes in minimally invasive, robotic-assisted cancer care, recently reached a deal to acquire NeuWave Medical, previously held by J&J.
Lantheus receives tentative FDA approval for its radio-equivalent to Lutathera
Lantheus’ version of a radiopharmaceutical capable of targeting somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has been tentatively approved by the FDA.
Ablation as effective as surgery for certain kidney cancers
Typically, these cancers are treated via surgical resection, but ablative techniques have gained recognition in recent years due to their less invasive nature.
FDA clears ultrasound AI tool for accurate delivery-date prediction
The cloud-based software service is able to predict a pregnant woman's delivery date using ultrasound imaging alone.

Radiology societies fight Medicare Administrative Contractor’s proposed coverage restriction

National Government Services is seeking to limit the use of thermal destruction of the intraosseous basivertebral nerve, aka the Intracept procedure, drawing ire from ACR and SIR.

mergers and acquisitions M&A consolidation puzzle business deal

Company seeks to become a ‘leader in interventional radiology’ with recent acquisition

Quantum Surgical, which specializes in minimally invasive, robotic-assisted cancer care, recently reached a deal to acquire NeuWave Medical, previously held by J&J.

Lantheus receives tentative FDA approval for its radio-equivalent to Lutathera

Lantheus’ version of a radiopharmaceutical capable of targeting somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has been tentatively approved by the FDA.

Ablation as effective as surgery for certain kidney cancers

Typically, these cancers are treated via surgical resection, but ablative techniques have gained recognition in recent years due to their less invasive nature.

FDA clears ultrasound AI tool for accurate delivery-date prediction

The cloud-based software service is able to predict a pregnant woman's delivery date using ultrasound imaging alone.

One PSMA agent outshines competitors at detecting prostate cancer recurrence

An ongoing study is evaluating how capably two PSMA agents assess urinary radioactivity and identify smaller lesions in post-prostatectomy patients with low PSA biochemical recurrence.

Ultrasound isn't cutting it for diagnosing pediatric appendicitis, new data show

Instead, rapid MRI protocols may be the key to addressing diagnostic questions in cases of suspected appendicitis in kids, researchers contend.

SCAI celebrates new federal funding for PAD prevention

The group's hope is that these new funds will help address the rising rates of PAD and CLTI throughout the United States.